Page last updated: 2024-08-16

technetium tc 99m sestamibi and poloxalene

technetium tc 99m sestamibi has been researched along with poloxalene in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Browne, KF; Edwards, S; Fletcher, WO; Gibbons, RJ; Grines, CL; Jolly, MK; Krichbaum, D; Krueger, KA; Phelan, JM; Schaer, GL; Spaccavento, LJ	1

Trials

1 trial(s) available for technetium tc 99m sestamibi and poloxalene

Article	Year
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. Circulation, 1996, Aug-01, Volume: 94, Issue:3 Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Double-Blind Method; Female; Fibrinolytic Agents; Humans; Injections; Male; Middle Aged; Myocardial Infarction; Placebos; Poloxalene; Salvage Therapy; Technetium Tc 99m Sestamibi; Thrombolytic Therapy; Treatment Outcome	1996

Article

Year

Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial.

Circulation, 1996, Aug-01, Volume: 94, Issue:3

Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Double-Blind Method; Female; Fibrinolytic Agents; Humans; Injections; Male; Middle Aged; Myocardial Infarction; Placebos; Poloxalene; Salvage Therapy; Technetium Tc 99m Sestamibi; Thrombolytic Therapy; Treatment Outcome

1996